These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 3125963)
1. Augmentation of murine natural killer cell activity by swainsonine, a new antimetastatic immunomodulator. Humphries MJ; Matsumoto K; White SL; Molyneux RJ; Olden K Cancer Res; 1988 Mar; 48(6):1410-5. PubMed ID: 3125963 [TBL] [Abstract][Full Text] [Related]
2. Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice. Gorelik E Cancer Res; 1987 Feb; 47(3):809-15. PubMed ID: 3802083 [TBL] [Abstract][Full Text] [Related]
3. Effects of the immunomodulator LS 2616 on growth and metastasis of the murine B16-F10 melanoma. Kalland T Cancer Res; 1986 Jun; 46(6):3018-22. PubMed ID: 3486041 [TBL] [Abstract][Full Text] [Related]
4. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. Wiltrout RH; Herberman RB; Zhang SR; Chirigos MA; Ortaldo JR; Green KM; Talmadge JE J Immunol; 1985 Jun; 134(6):4267-75. PubMed ID: 3989307 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of experimental metastasis by castanospermine in mice: blockage of two distinct stages of tumor colonization by oligosaccharide processing inhibitors. Humphries MJ; Matsumoto K; White SL; Olden K Cancer Res; 1986 Oct; 46(10):5215-22. PubMed ID: 3093061 [TBL] [Abstract][Full Text] [Related]
6. In vivo effects of recombinant human interleukin 2 on antitumor and antiviral natural immunity in induced or natural murine immunodeficiency states. Butler LD; Browne CP; Layman NK; Riedl P; Tang J; Marder P; DeLong D; Manetta J; Bobbitt L; Strnad J Cancer Res; 1988 Nov; 48(21):6081-9. PubMed ID: 3048654 [TBL] [Abstract][Full Text] [Related]
7. Inability of anti-asialo-GM1 and 2-chloroadenosine to abrogate maleic anhydride-divinyl ether-induced resistance against experimental murine lung carcinoma metastases. Schultz RM; Tang JC; DeLong DC; Ades EW; Altom MG Cancer Res; 1986 Nov; 46(11):5624-8. PubMed ID: 3756909 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of intravascular mouse melanoma dissemination by recombinant human interferon alpha A/D. Yokoyama T; Yoshie O; Aso H; Ebina T; Ishida N Jpn J Cancer Res; 1986 Jan; 77(1):80-4. PubMed ID: 3082819 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia. Li LH; Wallace TL; Richard KA; Tracey DE Cancer Res; 1985 Feb; 45(2):532-8. PubMed ID: 3967227 [TBL] [Abstract][Full Text] [Related]
10. [Role of asialo GM 1 positive cells in the control of metastatic spread of tumor cells in mice]. Shibuya M; Saijo N; Ozaki A; Beppu Y; Shimizu E; Takizawa T; Hoshi A Gan To Kagaku Ryoho; 1983 Aug; 10(8):1781-6. PubMed ID: 6882003 [TBL] [Abstract][Full Text] [Related]
11. Role of natural killer cells and macrophages in the nonspecific resistance to tumors in mice stimulated with SMANCS, a polymer-conjugated derivative of neocarzinostatin. Suzuki F; Pollard RB; Uchimura S; Munakata T; Maeda H Cancer Res; 1990 Jul; 50(13):3897-904. PubMed ID: 2141295 [TBL] [Abstract][Full Text] [Related]
12. Synergistic defense system by cooperative natural effectors against metastasis of B16 melanoma cells in H-2-associated control: different behavior of H-2+ and H-2- cells in metastatic processes. Kawano Y; Taniguchi K; Toshitani A; Nomoto K J Immunol; 1986 Jun; 136(12):4729-34. PubMed ID: 3711664 [TBL] [Abstract][Full Text] [Related]
13. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity. Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715 [TBL] [Abstract][Full Text] [Related]
14. Expression of asialo GM1 and other antigens and glycolipids on natural killer cells and spleen leukocytes in virus-infected mice. Yang H; Yogeeswaran G; Bukowski JF; Welsh RM Nat Immun Cell Growth Regul; 1985; 4(1):21-39. PubMed ID: 3875791 [TBL] [Abstract][Full Text] [Related]
15. The modulation of B16BL6 melanoma metastasis is not directly mediated by cytolytic activity of natural killer cells in alcohol-consuming mice. Spitzer JH; Núñez NP; Meadows SA; Gallucci RM; Blank SE; Meadows GG Alcohol Clin Exp Res; 2000 Jun; 24(6):837-44. PubMed ID: 10888072 [TBL] [Abstract][Full Text] [Related]
16. Purification and target cell range of in vivo elicited blast natural killer cells. Biron CA; Pedersen KF; Welsh RM J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814 [TBL] [Abstract][Full Text] [Related]
17. Correlation of suppressed natural killer cell activity with altered host resistance models in B6C3F1 mice. Wilson SD; McCay JA; Butterworth LF; Munson AE; White KL Toxicol Appl Pharmacol; 2001 Dec; 177(3):208-18. PubMed ID: 11749120 [TBL] [Abstract][Full Text] [Related]
18. Swainsonine: a new antineoplastic immunomodulator. Mohla S; Humphries MJ; White SL; Matsumoto K; Newton SA; Sampson CC; Bowen D; Olden K J Natl Med Assoc; 1989 Oct; 81(10):1049-56. PubMed ID: 2509720 [TBL] [Abstract][Full Text] [Related]
19. Potentiation of natural killer cell activity and tumor immunity by diacetylputrescine. Bowlin TL; Rosenberger A; Stemerick D; Edwards ML Cancer Res; 1990 Sep; 50(17):5460-3. PubMed ID: 2386950 [TBL] [Abstract][Full Text] [Related]
20. [Antimetastatic action of polyactin A and its mechanism]. Qiang WA; Liu JR; Wang YS; Lei YD Yao Xue Xue Bao; 1994; 29(5):340-5. PubMed ID: 7976351 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]